pubrio
Parse Biosciences logo

Parse Biosciences

Privately Held
研究產業200+ employeesFounded 2018🇺🇸 美國
總部
🇺🇸700 Dexter Ave N, Suite 600, Seattle, Washington 98109, US (+2)
行業
研究產業
員工
200+
成立年份
2018
公司類型
Privately Held
排名
#3,169,246

Parse Biosciences is a biotechnology company based in Seattle, founded in 2018. The company focuses on advancing single-cell genomics with innovative solutions that allow researchers to analyze complex biological systems efficiently. Their mission is to support breakthroughs in various fields, including developmental biology, immunotherapy, neurology, diabetes, vascular disease, and cancer. The company specializes in single-cell sequencing technologies, particularly through their Evercode™ Platform. This platform provides an end-to-end solution for library preparation, sequencing, and data analysis, enabling whole transcriptome sequencing and immune profiling without the need for custom instruments. Their offerings include Evercode™ Whole Transcriptome Kits and Immune Profiling Kits, which facilitate scalable workflows and detailed immune repertoire analysis. Parse Biosciences serves researchers and institutions in academic, clinical, and pharmaceutical settings, providing tools that enhance the study of cellular heterogeneity and disease mechanisms.

專長
研究產業生物技術醫療保健
5 / 6
活躍市場
United Kingdom · Germany · France
1
新市場
Russia
762
訊號
過去 90 日
-48%
動能
對比上一週期
擴張評分初期
12 / 100

全球擴張

即時
United KingdomGermanyFrance
最多 3 個市場
過去 90 日
階段
探索中6投入中0拓展中0規模化中0
近期動態
推進中30天
新增90天
+3個市場已鎖定
已顯示 6 個中的 3 個

解鎖市場時間軸與訊號動態

活動脈搏

全新 招聘 活動 — 剛出現 2 個新訊號。

過去 90 日
招聘
2新增
招聘
市場推廣與公關
760-29%
廣告
產品與技術
0
無活動
+2個類別已鎖定
已顯示 5 個中的 3 個

市場進入時間軸

此公司進入各市場的次序 — 由最舊至最新

1
🇬🇧United Kingdom第 1st 個進入的市場 · 2024
探索中
102 個訊號
2
🇩🇪Germany第 2nd 個進入的市場 · 2024
探索中
101 個訊號
3
🇫🇷France第 3rd 個進入的市場 · 2024
探索中
100 個訊號
+3個市場已鎖定
已顯示 6 個中的 3 個
目前階段探索中試水溫
信心度48%
開始追蹤於2024首個訊號

近期訊號

廣告🇬🇧 United Kingdom今日

If you're doing single cell in 2026, you need to be in this room. Join us in London, January 27, for the Parse Biosciences user group meeting, featuring:🗣️ Customer talks on real-world applications📰 Latest Parse updates💬 Open discussion to swap approaches and best practices🤝 Networking with fellow single cell researchersRegister now: https://lnkd.in/dvr7CCMK ...

廣告🇯🇵 Japan昨日

[On-Demand Webinar] Why Single Cell RNA Sequencing?

註冊以查看完整訊號動態

值得了解

關於 Parse Biosciences 的常見問題

關於 Parse Biosciences 業務、市場及增長訊號的快速解答。

Parse Biosciences is a biotechnology company based in Seattle, founded in 2018. The company focuses on advancing single-cell genomics with innovative solutions that allow researchers to analyze complex biological systems efficiently. Their mission is to support breakthroughs in various fields, including developmental biology, immunotherapy, neurology, diabetes, vascular disease, and cancer. The company specializes in single-cell sequencing technologies, particularly through their Evercode™ Platform. This platform provides an end-to-end solution for library preparation, sequencing, and data analysis, enabling whole transcriptome sequencing and immune profiling without the need for custom instruments. Their offerings include Evercode™ Whole Transcriptome Kits and Immune Profiling Kits, which facilitate scalable workflows and detailed immune repertoire analysis. Parse Biosciences serves researchers and institutions in academic, clinical, and pharmaceutical settings, providing tools that enhance the study of cellular heterogeneity and disease mechanisms.

800M+
監測企業
50+
本地數據來源
16
動向訊號
每日
更新頻率
「企業進駐市場的那一週,我們就接觸到他們——而非一季之後。」
增長主管 · Pubrio 上一支 500+ 人的營收團隊

洞察全球企業的每一步動向。

與我們的團隊預約一次動向地圖導覽。

pubrio

Pubrio 把橫跨 200+ 個市場的擴張訊號整合為一張即時圖譜,讓營收團隊看見哪些公司正進軍新市場,並把握時機。

追蹤

向 AI 了解 Pubrio

© 2026 Pubrio。版權所有。